PlainPharmaWatch

CMS Open Payments · Tool

Cg Medtech USA, Inc vs World Class Technology Corporation

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Cg Medtech USA, Inc has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 2,257, versus 863 for the other company. Its single largest recorded recipient represents 40.4% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Cg Medtech USA, Inc
HHI 2,257 · top recipient 40.4%
Ranked #704 of 1,838 companies by HHI
World Class Technology Corporation
HHI 863 · top recipient 27.3%
Ranked #1,082 of 1,838 companies by HHI

Payment Overview

Total Payments
$123.9K
% of Industry
0.0%
Transactions
13
Avg per Transaction
$9.5K
Recipients
13
Avg per Recipient
$9.5K
Payment Types
3
Top Payment Type
Royalty or License
Total Payments
$124.1K
% of Industry
0.0%
Transactions
1,299
Avg per Transaction
$95.55
Recipients
1,299
Avg per Recipient
$95.55
Payment Types
5
Top Payment Type
Food and Beverage

Highlighted values indicate the higher figure for each metric.

Total payments compared

Cg Medtech USA, Inc vs World Class Technology Corporation - total reported payments in CMS Open Payments PY2024

World Class Technology Corp…$124.1KCg Medtech USA, Inc$123.9K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Cg Medtech USA, Inc

Royalty or License $103.0K

83.1%

Consulting Fee $14.9K

12.0%

Education $6.0K

4.8%

World Class Technology Corporation

Food and Beverage $63.8K

51.4%

Compensation for Services Other Than Consulting $47.6K

38.4%

Travel and Lodging $6.4K

5.2%

Entertainment $3.6K

2.9%

Gift $2.7K

2.2%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Cg Medtech USA, Inc

  1. 1

    ROBERT BRAY

    $50,000.00 · 1 txns

  2. 2

    AYMAN SALEM

    $19,884.74 · 1 txns

  3. 3

    MICHAEL D BURDI

    $15,723.98 · 3 txns

  4. 4

    DOUGLAS SLAUGHTER

    $12,403.94 · 1 txns

  5. 5

    LARRY KHOO

    $8,875.00 · 2 txns

World Class Technology Corporation

  1. 1

    THOMAS PITTS

    $33,835.60 · 44 txns

  2. 2

    MATTHEW BRUNER

    $7,820.52 · 12 txns

  3. 3

    JOHN POBANZ

    $6,783.19 · 10 txns

  4. 4

    LEAH WALKER

    $6,685.80 · 28 txns

  5. 5

    JUSTIN DANIEL MACCARO

    $2,494.02 · 3 txns

Summary Comparison

Metric Cg Medtech USA, Inc World Class Technology Corporation
Total Payments $123.9K $124.1K
% of Industry Total 0.0% 0.0%
Transaction Count 13 1,299
Avg per Transaction $9.5K $95.55
Recipient Count 13 1,299
Avg per Recipient $9.5K $95.55
Payment Type Count 3 5
Top Payment Type Royalty or License Food and Beverage

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.